PR93717 

DAYTON, Ohio and LONG CRENDON, Buckinghamshire, England, Dec. 16, 2021 /PRNewswire=KYODO JBN

CSafe Global (

https://c212.net/c/link/?t=0&l=en&o=3390005-1&h=3574198711&u=https%3A%2F%2Fcsafeglobal.com%2F&a=CSafe+Global

), the leader in temperature-controlled container solutions for the

pharmaceutical industry, announced today that it has acquired Softbox Systems (

https://c212.net/c/link/?t=0&l=en&o=3390005-1&h=3932623682&u=https%3A%2F%2Fwww.softboxsystems.com%2F&a=Softbox+Systems

), a provider of passive temperature-controlled packaging solutions for the

pharmaceutical, life science and cold chain logistics industries, significantly

enhancing CSafe's passive product portfolio. Together, they will provide the

most comprehensive suite of thermal shipping solutions and become a

one-stop-shop for all pharmaceutical cold chain shipping needs, enabling

delivery of critical temperature-sensitive products, including next generation

biologics, cell and gene therapy, and mRNA therapies such as the COVID-19

vaccine.

Logo -

https://mma.prnewswire.com/media/1710412/Softbox_Sytems_and_CSafe_Global_Logo.jpg

The combined company, which will operate globally under the CSafe brand, will

be the only cold chain platform with an end-to-end active air cargo and passive

temperature-controlled packaging business spanning the complete spectrum of

cold chain shipping solutions for the pharmaceutical and life sciences

industries. Softbox's well-regarded brands in the passive container space, such

as SilverSkin, Silverpod and Tempcell, complement CSafe's leading active

product portfolio, particularly within air cargo. The acquisition will unlock

opportunities for innovation as well as enhance CSafe's sustainable and

eco-friendly offerings, with new reusable and recyclable pallet and parcel

solutions.

Around the globe, a large industry pipeline of life-saving pharmaceutical

therapies with strict temperature profiles is accelerating the need for

reliable, temperature-controlled shipping solutions. Moreover, future

pharmaceutical advances will require a new generation of qualified

fit-for-purpose packaging, along with sophisticated tracking technology, that

also helps customers meet their sustainability and recycling goals.

"Through this combination, we will be the partner of choice for cold chain

delivery of high value, temperature sensitive pharmaceutical therapies. Both

CSafe and Softbox have proven to be reliable partners for customers seeking a

secure way to deliver their life-enhancing products around the world," said

Patrick Schafer, CSafe CEO. "We're thrilled to now offer our customers a

platform that provides everything from the highest quality packaging to

AI-enabled thermal and kinetic monitoring and logistics management."

"Our businesses are each rooted in a commitment to excellent customer service

and high product quality, which made this combination a natural fit," said

Kevin Valentine, CEO of Softbox. "Together we will proudly continue to partner

with our global Pharmaceutical customers to devise and deliver the best

solutions for their evolving cold chain shipping needs, supporting the delivery

of temperature sensitive lifesaving medicines and vaccines.

"With the addition of Softbox's product portfolio, CSafe strengthens its global

infrastructure across air and ground while expanding its offerings for parcel

delivery, all supported by the most advanced technology infrastructure," said

Todd Abbrecht, Co-CEO of Thomas H. Lee Partners, which first invested in CSafe

in 2016. "We see an incredible opportunity for the combined company to serve as

the international partner of choice for cold chain shipping solutions and

remain on the forefront of innovation in the industry."

"The acquisition of Softbox advances CSafe's strategy to be the leading cold

chain solutions provider with a full suite of products and services to meet the

needs of its pharmaceutical customers around the globe," said Ben Magnano,

Co-Managing Partner of Frazier Healthcare Partners. "CSafe is an excellent

platform to build upon and we, alongside our partners at THL, will continue to

make investments to further strengthen the Company's leadership position in

pharmaceutical cold chain."

As part of the acquisition, Softbox CEO Kevin Valentine will assume the role of

president of CSafe's Passive Temperature Controlled Packaging Division.

Terms of the transaction were not disclosed.

Media Contact:

For CSafe Global and Softbox Systems:

Lori Conaway

+1 405.633.2344

lconaway@csafeglobal.com

About CSafe Global

CSafe Global provides end-to-end thermal shipping solutions to the

pharmaceutical and life science industries worldwide. An industry innovator,

CSafe is the only provider of both active and passive solutions and offers

AI-enabled lease forecasting to ensure active container availability and

real-time shipment visibility for active and passive containers. CSafe provides

industry-leading maintenance and reuse programs ensuring superior product

performance and alignment with customer sustainability objectives. With a

presence in 150 countries, 24/7 support and 100% container availability, CSafe

is well-positioned to be the partner of choice in the cold chain.

csafeglobal.com (

https://c212.net/c/link/?t=0&l=en&o=3390005-1&h=3207582229&u=https%3A%2F%2Fcsafeglobal.com%2F&a=csafeglobal.com

)

About Softbox

Softbox is an award-winning temperature control packaging innovator that has

been designing and producing high performance passive temperature control

packaging solutions for over 25 years. We offer consistent quality to our

clients from our strategically located global manufacturing sites throughout

Europe, Americas, India and Asia Pacific. We have formed long standing

partnerships with the world's leading pharmaceutical, clinical research,

biotech and logistics companies, and apply innovative thinking to overcome the

challenges that our clients face in managing the Cold Chain when shipping

temperature sensitive clinical trial and commercialised products. For more

information about Softbox, visit www.softboxsystems.com

About Thomas H. Lee Partners

Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing

in middle-market growth companies exclusively in three sectors: Financial

Services, Healthcare, and Technology & Business Solutions. THL couples deep

sector expertise through our Identified Sector Opportunity ("ISO") process with

dedicated internal operating resources from our Strategic Resource Group

("SRG") to transform and build great companies of lasting value in partnership

with management. The Firm's domain expertise and resources help to build great

companies with an aim to accelerate growth, improve operations and drive

long-term sustainable value. Since 1974, THL has raised more than $30 billion

of equity capital, invested in over 160 companies and completed more than 500

add-on acquisitions representing an aggregate enterprise value at acquisition

of over $210 billion. For more information, please visit www.thl.com.

About Frazier Healthcare Partners:

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth

and venture capital to healthcare companies. With over $7 billion in total

capital raised, Frazier has invested in more than 200 companies with

transaction types ranging from buyouts of profitable healthcare services

companies to venture capital and company creation. Frazier has a philosophy of

partnering with strong management teams while leveraging its internal operating

resources and network to build exceptional companies. Frazier has offices in

Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada,

and Europe. For more information about Frazier Healthcare Partners, visit

www.frazierhealthcare.com.

SOURCE  CSafe Global